Pharmacokinetics of Rifampin and Clarithromycin in Patients Treated for Mycobacterium ulcerans Infection

In a randomized controlled trial in Ghana, treatment of Mycobacterium ulcerans infection with streptomycin (SM)-rifampin (RIF) for 8 weeks was compared with treatment with SM-RIF for 4 weeks followed by treatment with RIF-clarithromycin (CLA) for 4 weeks. The extent of the interaction of RIF and CLA...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Alffenaar, J. W. C., Nienhuis, W. A., de Velde, F., Zuur, A. T., Wessels, A. M. A., Almeida, D., Grosset, J., Adjei, O., Uges, D. R. A., van der Werf, T. S.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2010
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935020/
https://ncbi.nlm.nih.gov/pubmed/20585115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00099-10
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires